Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology  ( EAACI )  Hybrid Congress 2023 - Allakos  ( NASDAQ:ALLK )